| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/28/1995 | US5392767 Atomizing a solution of furosemide |
| 02/28/1995 | CA1334576C Antiviral pharmaceutical compositions and process for preparing same |
| 02/23/1995 | WO1995005600A1 Methods of detecting and combating disorders of the central nervous system |
| 02/23/1995 | WO1995005386A1 Phenethylamine compounds |
| 02/23/1995 | WO1995005376A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
| 02/23/1995 | WO1995005363A1 Amidine derivatives with nitric oxide synthetase activities |
| 02/23/1995 | WO1995005360A1 Phenoxyphenyl cyclopentenyl hydroxyureas |
| 02/23/1995 | WO1995005186A1 Ruthenium red as an inhibitor of the immune response |
| 02/23/1995 | CA2169280A1 Amidine derivatives with nitric oxide synthetase activities |
| 02/23/1995 | CA2169273A1 Methods of detecting and combating disorders of the central nervous system |
| 02/23/1995 | CA2165567A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelien antagonists |
| 02/22/1995 | EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| 02/22/1995 | EP0639182A1 Quinoline derivatives |
| 02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 02/22/1995 | EP0639071A1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil |
| 02/22/1995 | EP0639070A1 Use of borate-polyol complexes in ophthalmic compositions |
| 02/21/1995 | US5391766 Antiarthritic agents for rheumatoid, immunosuppressants; treating psoriasis, autoimmune diseases |
| 02/21/1995 | US5391758 Heterocyclic amide derivatives |
| 02/21/1995 | CA2006144C Microbial process for the production of immunosuppressive antibiotics |
| 02/21/1995 | CA1334508C Method of inhibiting the activity of leukocyte derived cytokines |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004751A1 Selectin binding glycopeptides |
| 02/16/1995 | WO1995004738A1 C-22 ring stabilized rapamycin derivatives |
| 02/16/1995 | WO1995004734A1 Hydroisoquinoline derivatives |
| 02/16/1995 | WO1995004548A1 Prostatic cancer vaccine |
| 02/16/1995 | WO1995004544A1 A method for sensitization of cancer cells for killer cell mediated lysis |
| 02/16/1995 | WO1994029451A3 Humanised antibodies |
| 02/16/1995 | CA2169277A1 C-22 ring stabilized rapamycin derivatives |
| 02/16/1995 | CA2168952A1 Prostatic cancer vaccine |
| 02/16/1995 | CA2168853A1 Hydroisoquinoline derivatives |
| 02/16/1995 | CA2168566A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 02/16/1995 | CA2168454A1 Selectin binding glycopeptides |
| 02/15/1995 | EP0638644A1 Receptors of interleukin-12 and antibodies |
| 02/15/1995 | EP0638311A1 Rejection inhibitor for transplants and il-1 production inhibitor |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638082A1 Macrocyclic immunomodulators |
| 02/15/1995 | EP0637963A1 Cd28 pathway immunoregulation |
| 02/15/1995 | EP0637915A1 Compositions and methods for regulating il-6 production in vivo |
| 02/15/1995 | EP0389570B1 High integrity liposomes and method of preration and use |
| 02/15/1995 | EP0344288B1 Method of inhibiting the activity of leukocyte derived cytokines |
| 02/15/1995 | CN1098714A 1H-indole-3-acetic acid hydrazide spla2 inhibitors |
| 02/14/1995 | US5389652 3-cycloalkyl-prop-2-enamides |
| 02/14/1995 | US5389650 Antiinflammatory agents, anticoagulants, antispasmodic agents |
| 02/14/1995 | US5389639 Amino alkanoic esters of rapamycin |
| 02/14/1995 | US5389633 Triazolopyridazine compounds, their production and use |
| 02/14/1995 | CA1334392C Immunosuppressant agent |
| 02/14/1995 | CA1334391C Immunosuppressant compound |
| 02/14/1995 | CA1334390C Glycoprotein growth modulation materials |
| 02/14/1995 | CA1334383C Method for treating autoimmune disease using succinylacetone |
| 02/09/1995 | WO1995004061A1 Activated macrolactams having immunomodulatory activities |
| 02/09/1995 | WO1995004060A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 02/09/1995 | WO1995004055A1 Thiazole derivatives as lipoxygenase inhibitors |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995004040A1 Perhydroisoindole derivatives as p substance antagonists |
| 02/09/1995 | WO1995003827A1 Method for treating multiple sclerosis |
| 02/09/1995 | WO1995003822A2 Use of relaxin as therapeutic or preventing agent |
| 02/09/1995 | WO1995003814A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 02/09/1995 | WO1995003794A1 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates |
| 02/09/1995 | WO1995003777A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 02/09/1995 | WO1995003701A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2168252A1 Thiazole derivatives as lipoxygenase inhibitors |
| 02/09/1995 | CA2168233A1 Perhydroisoindole derivatives as substance p antagonists |
| 02/09/1995 | CA2168098A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2166892A1 Activated macrolactams having immunomodulatory activities |
| 02/09/1995 | CA2145515A1 Use of relaxin as therapeutic or preventing agent |
| 02/08/1995 | EP0637299A1 20-methyl-substituted vitamin d derivates. |
| 02/08/1995 | EP0637249A1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/08/1995 | CN1098404A Inhibitors of HIV protease useful for the treatment of aids |
| 02/08/1995 | CN1098309A Traditional Chinese medicine capsule for treating rheumatoid arthritis |
| 02/07/1995 | US5387680 Immunosuppressants; useful to treat transplant rejection and autoimmune disorders |
| 02/07/1995 | US5387670 Antibiotic, deoxymulundocandin, a process for its production and its use as medicament |
| 02/07/1995 | US5387615 L-deprenyl for treating immune system dysfunction and compositions for same |
| 02/07/1995 | US5387582 Vitamin D analogues |
| 02/07/1995 | US5387579 Use of α-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained |
| 02/07/1995 | CA2029704C Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003325A1 Protegrins |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003313A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/02/1995 | WO1995003292A1 Heteroaryl cycloalkenyl hydroxyureas |
| 02/02/1995 | WO1995003273A1 Vitamin d analogues |
| 02/02/1995 | WO1995003266A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
| 02/02/1995 | WO1995003084A2 Extracorporeal affinity adsorption devices |
| 02/02/1995 | WO1995003054A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | WO1995003042A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes |
| 02/02/1995 | WO1995002967A1 Viscous liquid xylitol compositions and method for preparing same |
| 02/02/1995 | CA2167843A1 Method of treating hiv with azaspiranes |
| 02/02/1995 | CA2167842A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes |
| 02/02/1995 | CA2167837A1 Vitamin d analogues |
| 02/02/1995 | CA2167821A1 New silylated benzylamine derivatives and their salts; process for producing the same and pharmaceutical compositions containing them |
| 02/02/1995 | CA2167805A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166788A1 Protegrins |
| 02/02/1995 | CA2145067A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |